Updates and Great Debates: Diagnosis & Treatment of Mild Pediatric OSA-Trouble-Shooting Treatment Failures (2022 AMW)
2022 AAO-HNSF Annual Meeting & OTO Experience
Pediatric obstructive sleep apnea (OSA) is characterized by upper airway obstruction, poor sleep, and daytime sequelae such as hyperactivity. Although controversy exists regarding the ideal evaluation for children with obstructive sleep‐disordered breathing, the severity of OSA is currently determined by overnight polysomnography (PSG). Mild OSA is defined by an apnea‐hypopnea index (AHI) > 1 and < 5. The majority (approximately 85%) of healthy school‐aged children evaluated by otolaryngologists for tonsil hypertrophy and obstructive symptoms have either primary snoring or mild OSA. This reality positions mild pediatric obstructive sleep apnea squarely in the domain of both general and pediatric otolaryngologists alike and served as the primary impetus for submitting this panel. The treatment of mild OSA in children is controversial. There is a lack of data on the natural history of mild sleep apnea. Furthermore, a poor correlation exists between quality of life (QOL) scores and OSA severity; mild OSA in children may have a significant impact on their general health and well‐being. High‐quality studies comparing observation, medical management, and surgery for mild pediatric OSA are just beginning to emerge. Many of these studies use varied measures to assess outcomes. Thus, it may be difficult for providers treating children with mild OSA to counsel parents on the optimal treatment for their child. This panel will employ a case-oriented approach to illustrate the current evidence-based best practice for this sub-population of patients. Audience response to case-related questions will precede responses by the panel. The specific areas to be discussed will include how the diagnosis is made, the need for PSG, the evidence correlating treatment with cognitive and behavioral outcomes, the role of DISE, medical and surgical treatments, the role of observation, non-surgical appliance and positional options, and the management of T&A treatment failures. The panel composed of national experts will provide "updates" and some "great debates" on areas that remain controversial.
Credits
CME:1.0, MOC:1.0